Addex Therapeutics SA, of Geneva, was issued U.S. Patent No...Anergis, of Epalinges, Switzerland, was issued U.S. Patent No...NeoStem Inc., of New York, was issued U.S. Patent No

Immunomedics Inc., of Morris Plains, N.J., was issued U.S. Patent No...MonoSol Rx LLC, of Warren, N.J., has acquired U.S. Patent No...RedHill Biopharma Ltd., of Tel-Aviv, Israel, was issued U.S. Patent No

Curis Inc., of Lexington, Mass., was issued U.S. Patent No...MiMedx Group Inc., of Kennesaw, Ga., was issued U.S. Patent No...Sequenom Inc., of San Diego, was issued U.S. Patent No

AtheroNova Inc., of Irvine, Calif., was issued U.S. Patent No...Curemark LLC, of Rye, N.Y., was issued U.S. Patent No...Dyadic International Inc., of Jupiter, Fla., was issued U.S. Patent No

Diffusion Pharmaceuticals LLC, of Charlottesville, Va., was granted U.S. Patent No...GeNO LLC, of Cocoa, Fla., was issued U.S. Patent Nos...Transcept Pharmaceuticals Inc., of Point Richmond, Calif., was issued U.S. Patent No

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., was issued U.S. Patent No...Aeterna Zentaris Inc., of Quebec City, was issued U.S. Patent No...Ziopharm Oncology Inc., of New York, was issued U.S. Patent No

Galectin Therapeutics Inc., of Newton, Mass., was issued U.S. Patent No...GeNO LLC, of Cocoa, Fla., was issued U.S. Patent No...Trovagene Inc., of San Diego, was issued U.S. Patent No

Derma Sciences Inc., of Princeton, N.J., was issued U.S. Patent Nos...Discovery Labs Inc., of Warrington, Pa., was issued U.S. Patent No...Nuvo Research Inc., of Mississauga, Ontario, was issued U.S. Patent No

The patent also is related to treating radiation-induced mucositis, a side effect of radiation treatment for cancer...The patent is related to a method for extending the company's BH3 profiling technology, licensed from Dana Farber Cancer Institute

Athersys Inc., of Cleveland, was issued Patent No...BioLineRx Ltd., of Jerusalem, received a patent term adjustment for its patent on the composition of BCM (BL-1040), a device for prevention of cardiac remodeling following acute myocardial infarction...The patent is now extended through April 30, 2029

Quest PharmaTech Inc., of Edmonton, Alberta, received a notice of allowance for a patent, titled "Combination Therapy for Treating Disease...Silence Therapeutics plc, of London, received a notice of allowance for a patent directed to the technology involved in AtuPLEX, one of its small interfering RNA delivery systems...Vermillion Inc., of Austin, Texas, received a notice of allowance for a patent, titled "Biomarkers for Peripheral Artery Disease

MultiCell Technologies Inc., of Woonsocket, R.I., was issued U.S. Patent No...Odyssey Thera Inc., of San Ramon, Calif., was granted U.S. Patent No

PolyTherics Ltd., of London, was issued a U.S...Vical Inc., of San Diego, was issued U.S. Patent No...Vitro Diagnostics Inc., of Golden, Colo., doing business as Vitro Biopharma, was awarded U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No...Orexigen Therapeutics Inc., of San Diego, was issued its "Weber/Cowley methods patent" (U.S. Patent No. 7,462,626), which covers methods of treating obesity with combinations of bupropion and naltrexone, the two active agents in Orexigen's lead drug, Contrave...Vical Inc., of San Diego, was issued U.S. Patent No

BioSante Pharmaceuticals Inc., of Lincolnshire, Ill., said its licensor Antares Pharma Inc., of Ewing, N.J., was issued U.S. Patent No...GeneNews Ltd., of Toronto, was granted U.S. Patent No

Alexion Pharmaceuticals Inc., of Cheshire, Conn., was granted U.S. Patent No...Banyan Biomarkers Inc., of Alachua, Fla., was granted U.S. Patent No

VASTox plc, of Oxford, UK, was granted a patent relating to its drug discovery program in Duchenne's muscular dystrophy...Vaxiion Therapeutics Inc., of San Diego, was issued U.S. Patent No

DiagnoCure Inc., of Quebec City, was granted U.S. Patent No

The patent would cover immunotherapy approaches directed against the 5T4 tumor antigen...Source MDx, of Boulder, Colo., was issued U.S. Patent No